The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 23: 3767 - 3772

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.23.020

Investigations

A cross‑sectional study of correlation between thyroid nodules and metabolic indicators of central obesity in Northwest China

  • Mingming ZHANG ,
  • Ke YAN ,
  • Hua HAO ,
  • Hong JIANG ,
  • Mao. MA
Expand
  • *.Department of Health Medicine，the First Affiliated Hospital of Xi'an Jiaotong University，Xi'an 710061，Shaanxi，China

Received date: 2025-08-29

  Online published: 2025-12-18

Fold

Abstract

Objective This study aims to provide theoretical support for the formulation of thyroid nodule prevention and treatment strategies in Northwest China and to investigate the characteristics of thyroid nodules and their association with metabolic indicators in this population. Methods A cross-sectional survey was conducted by retrospectively enrolling healthy individuals who underwent routine health examinations at our hospital between January 1 and December 31， 2023. A total of 38 919 participants were included. The detection rate of thyroid nodules was stratified by age and sex. Univariate and multivariate binary logistic regression analyses were performed to identify risk factors for thyroid nodules. Results Among the 38 919 participants， 20 395 were men （52.4%） and 18 524 were women （47.6%）. The overall detection rate of thyroid nodules was 47.1% （18 317/38 919）， including 40.1% （8 187/20 395） in men and 54.7% （10 130/18 524） in women. Across all age groups， women had a significantly higher detection rate than men （P < 0.001）. The detection rate increased with age in both sexes （χ2trend = 1392.867， P < 0.001 in men； χ2trend = 1521.215， P < 0.001 in women）. Significant differences were observed between participants with and without thyroid nodules in age， body mass index （BMI）， fasting blood glucose （FBG）， glycated hemoglobin （HbA1c）， total cholesterol （TC）， low-density lipoprotein cholesterol （LDL-C）， triiodothyronine （T3）， thyroid-stimulating hormone （TSH）， and anti-thyroglobulin antibodies （TGAB）， anti-thyroid microsomal antibodies， the proportion of hypertension and central obesity （all P < 0.05）. Multivariate binary logistic regression analysis identified female sex （OR = 2.158）， older age （OR = 1.040）， central obesity （OR = 1.144）， elevated FBG （OR = 1.039）， hypertension （OR = 1.095）， elevated TGAB （OR = 1.008）， and elevated T3 （OR = 1.154） as independent risk factors for thyroid nodules （all P < 0.05）. Conclusion Women in Northwest China are at higher risk of developing thyroid nodules. Screening and health management should be prioritized for older individuals， those with central obesity， elevated FBG， hypertension， elevated TGAB， and elevated T3 levels.

Key words： thyroid nodules; metabolic indicators; central obesity; northwest China

Cite this article

Mingming ZHANG , Ke YAN , Hua HAO , Hong JIANG , Mao. MA . A cross‑sectional study of correlation between thyroid nodules and metabolic indicators of central obesity in Northwest China[J]. The Journal of Practical Medicine, 2025 , 41(23) : 3767 -3772 . DOI: 10.3969/j.issn.1006-5725.2025.23.020

References

[1] ALEXANDER E K， CIBAS E S. Diagnosis of thyroid nodules［J］. Lancet Diabetes Endocrinol， 2022， 10（7）： 533-539. doi:10.1016/s2213-8587(22)00101-2
[2] DURANTE C， GRANI G， LAMARTINA L， et al. The Diagnosis and Management of Thyroid Nodules： A Review［J］. JAMA， 2018， 319（9）： 914-924. doi:10.1001/jama.2018.0898
[3] LI Y Z， TENG D， BA J M， et al. Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders： Epidemiological Evidence from 31 Provinces of Mainland China［J］. Thyroid， 2020， 30（4）： 568-579. doi:10.1089/thy.2019.0067
[4] 唐艺峰， 王龙龙， 刘益豪， 等. 2cm以上的C-TI-RADS 3类甲状腺结节的临床特点分析［J］. 西安交通大学学报（医学版）， 2024， 45（1）： 74-79.
[5] 伍朝春， 黄政德， 庞羽， 等. 广西地区67 990例体检人群甲状腺结节检出情况及危险因素分析［J］. 广东医学， 2022， 43（8）： 930-933.
[6] 胡珊， 庄一渝， 朱炜琴， 等. 健康体检人群甲状腺结节检出情况及相关因素分析［J］. 中华保健医学杂志， 2023， 25（2）： 196-199.
[7] 贤晓敏， 余文韬， 杜隆德， 等. 深圳地区甲状腺结节检出率与血脂、BMI的相关性分析［J］. 临床内科杂志， 2024， 41（8）： 563-565.
[8] 中华医学会内分泌学分会， 中华医学会外科学分会甲状腺及代谢外科学组， 中国抗癌协会头颈肿瘤专业委员会， 等. 甲状腺结节和分化型甲状腺癌诊治指南（第二版）［J］. 中华内分泌代谢杂志， 2023， 39（3）： 181-226.
[9] XU L， ZENG F L， WANG Y T， et al. Prevalence and associated metabolic factors for thyroid nodules：A cross-sectional study in Southwest of China with more than 120 thousand populations［J］. BMC Endocr Disord， 2021， 21（1）： 175. doi:10.1186/s12902-021-00842-2
[10] WAN Z Y， LI Y， DONG X Q， et al. Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men：a cross-sectional study［J］. Eur Thyroid J， 2023， 12（6）： e230168. doi:10.1530/etj-23-0168
[11] ZHANG C Y， GAO X T， HAN Y T， et al. Correlation Between Thyroid Nodules and Metabolic Syndrome：A Systematic Review and Meta-Analysis［J］. Front Endocrinol， 2021， 12： 730279. doi:10.3389/fendo.2021.730279
[12] TESSLER FN， MIDDLETON WD， GRANT EG， et al. ACR Thyroid Imaging， Reporting and Data System（TI-RADS）：White Paper of the ACR TI-RADS Committee［J］. J Am Coll Radiol， 2017， 14（5）： 587-595. doi:10.1016/j.jacr.2017.01.046
[13] 于钏钏， 王强. 2008-2014年我国健康成人甲状腺结节流行特征及影响因素初步分析［J］. 环境与健康杂志， 2016， 33（5）： 440-443.
[14] KWONG N， MEDICI M， ANGELL TE， et al. The Influence of Patient Age on Thyroid Nodule Formation， Multinodularity， and Thyroid Cancer Risk［J］. J Clin Endocrinol Metab， 2015， 100（12）： 4434-4440. doi:10.1210/jc.2015-3100
[15] 白一彤， 林连捷， 裴冬梅. 代谢相关性脂肪性肝病严重程度与甲状腺结节的相关性研究［J］. 中国全科医学， 2023， 26（27）： 3392-3396.
[16] PASQUAL E， O'BRIEN K， RINALDI S， et al. Obesity， obesity-related metabolic conditions， and risk of thyroid cancer in women： Results from a prospective cohort study（Sister Study）［J］. Lancet Reg Health Am， 2023， 23： 100537. doi:10.1016/j.lana.2023.100537
[17] COSTA ESRH， BROOKS VL. The growing complexity of the control of the hypothalamic pituitary thyroid axis and brown adipose tissue by leptin［J］. Vitam Horm， 2025， 127： 305-362. doi:10.1016/bs.vh.2024.07.005
[18] VAN TIENHOVEN-WIND LJN， DULLAART RPF. Increased leptin/adiponectin ratio relates to low-normal thyroid function in metabolic syndrome［J］. Lipids Health Dis， 2017， 16（1）： 6. doi:10.1186/s12944-016-0403-4
[19] TIROSH A， SHIMON I. Complications of acromegaly：thyroid and colon［J］. Pituitary， 2017， 20（1）： 70-75. doi:10.1007/s11102-016-0744-z
[20] FIERABRACCI P， BASOLO A， SCARTABELLI G， et al. Possible added value of thyroglobulin antibody（TgAb）testing in the evaluation of thyroidal status of subjects with overweight or obesity［J］. J Endocrinol Inves， 2022， 45（11）： 2077-2084. doi:10.1007/s40618-022-01839-x
[21] JIANG N， JIAO B Z， ZHANG L， et al. Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma［J］. Ann Med， 2023， 55（1）： 2232372. doi:10.1080/07853890.2023.2232372
[22] LI Z， HUANG Y， CHEN X， et al. The Effect of Inflammation on the Formation of Thyroid Nodules［J］. Int J Endocrinol， 2020， 2020： 9827349. doi:10.1155/2020/9827349
[23] MANCINI A， DI SEGNI C， RAIMONDO S， et al. Thyroid Hormones， Oxidative stress， and Inflammation［J］. Mediators Inflamm， 2016， 2016： 6757154. doi:10.1155/2016/6757154
[24] LE BRAS M， CLéMENT M V， BRENNER C， et al. Reactive oxygen species and the mitochondrial signaling pathway of cell death［J］. Histol Histopathol， 2005， 20（1）： 205-219.
[25] RESCH U， HELSEL G， TATZBER F， et al. Antioxidant status in thyroid dysfunction［J］. Clin Chem Lab Med， 2002， 40（11）： 1132-1134. doi:10.1515/cclm.2002.198
Options
Outlines

/

〈 〉